Literature DB >> 21399714

Clinical applications of miRNAs in cardiac remodeling and heart failure.

Veli K Topkara1, Douglas L Mann.   

Abstract

MicroRNAs (miRNAs or miRs) are short, highly conserved noncoding RNAs that regulate gene expression at the post-transcriptional level by inhibiting translation or promoting the degradation of target mRNA. Even though the field of miRNA biology is relatively young, growing lines of evidence suggest that miRNAs play a key role pathogenesis of heart failure through their ability to regulate genes that govern the process of adaptive and maladaptive cardiac remodeling. Herein, we review the biology of miRNAs in relation to their role in modulating various aspects of the cardiac remodeling process, as well as discuss the potential applications of miRNA biology to the field of heart failure.

Entities:  

Year:  2010        PMID: 21399714      PMCID: PMC3050537          DOI: 10.2217/pme.10.44

Source DB:  PubMed          Journal:  Per Med        ISSN: 1741-0541            Impact factor:   2.512


  72 in total

1.  Phylogenetic shadowing and computational identification of human microRNA genes.

Authors:  Eugene Berezikov; Victor Guryev; José van de Belt; Erno Wienholds; Ronald H A Plasterk; Edwin Cuppen
Journal:  Cell       Date:  2005-01-14       Impact factor: 41.582

Review 2.  MicroRNAs: powerful new regulators of heart disease and provocative therapeutic targets.

Authors:  Eva van Rooij; Eric N Olson
Journal:  J Clin Invest       Date:  2007-09       Impact factor: 14.808

3.  Isolated myocyte contractile function is normal in postinfarct remodeled rat heart with systolic dysfunction.

Authors:  I S Anand; D Liu; S S Chugh; A J Prahash; S Gupta; R John; F Popescu; Y Chandrashekhar
Journal:  Circulation       Date:  1997-12-02       Impact factor: 29.690

4.  Myosin heavy chain gene expression in human heart failure.

Authors:  K Nakao; W Minobe; R Roden; M R Bristow; L A Leinwand
Journal:  J Clin Invest       Date:  1997-11-01       Impact factor: 14.808

5.  A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure.

Authors:  Eva van Rooij; Lillian B Sutherland; Ning Liu; Andrew H Williams; John McAnally; Robert D Gerard; James A Richardson; Eric N Olson
Journal:  Proc Natl Acad Sci U S A       Date:  2006-11-15       Impact factor: 11.205

6.  Expression of microRNAs is dynamically regulated during cardiomyocyte hypertrophy.

Authors:  Mariko Tatsuguchi; Hee Young Seok; Thomas E Callis; J Michael Thomson; Jian-Fu Chen; Martin Newman; Mauricio Rojas; Scott M Hammond; Da-Zhi Wang
Journal:  J Mol Cell Cardiol       Date:  2007-04-14       Impact factor: 5.000

7.  miR-1 overexpression enhances Ca(2+) release and promotes cardiac arrhythmogenesis by targeting PP2A regulatory subunit B56alpha and causing CaMKII-dependent hyperphosphorylation of RyR2.

Authors:  Dmitry Terentyev; Andriy E Belevych; Radmila Terentyeva; Mickey M Martin; Geraldine E Malana; Donald E Kuhn; Maha Abdellatif; David S Feldman; Terry S Elton; Sandor Györke
Journal:  Circ Res       Date:  2009-01-08       Impact factor: 17.367

Review 8.  MiRSNPs or MiR-polymorphisms, new players in microRNA mediated regulation of the cell: Introducing microRNA pharmacogenomics.

Authors:  Prasun J Mishra; Pravin J Mishra; Debabrata Banerjee; Joseph R Bertino
Journal:  Cell Cycle       Date:  2008-01-28       Impact factor: 4.534

9.  Human polymorphism at microRNAs and microRNA target sites.

Authors:  Matthew A Saunders; Han Liang; Wen-Hsiung Li
Journal:  Proc Natl Acad Sci U S A       Date:  2007-02-20       Impact factor: 11.205

10.  Loss of cardiac microRNA-mediated regulation leads to dilated cardiomyopathy and heart failure.

Authors:  Prakash K Rao; Yumiko Toyama; H Rosaria Chiang; Sumeet Gupta; Michael Bauer; Rostislav Medvid; Ferenc Reinhardt; Ronglih Liao; Monty Krieger; Rudolf Jaenisch; Harvey F Lodish; Robert Blelloch
Journal:  Circ Res       Date:  2009-08-13       Impact factor: 17.367

View more
  10 in total

Review 1.  Thyroid hormones and cardiac remodeling.

Authors:  Dennis V Cokkinos; Stavros Chryssanthopoulos
Journal:  Heart Fail Rev       Date:  2016-07       Impact factor: 4.214

Review 2.  Left ventricular assist device-induced reverse remodeling: it's not just about myocardial recovery.

Authors:  Karolina K Marinescu; Nir Uriel; Douglas L Mann; Daniel Burkhoff
Journal:  Expert Rev Med Devices       Date:  2016-12-22       Impact factor: 3.166

Review 3.  Left Ventricular Remodelling: A Problem in Search of Solutions.

Authors:  Dennis V Cokkinos; Christos Belogianneas
Journal:  Eur Cardiol       Date:  2016-08

4.  Cardiac hypertrophy is positively regulated by MicroRNA miR-23a.

Authors:  Kun Wang; Zhi-Qiang Lin; Bo Long; Jian-Hui Li; Jing Zhou; Pei-Feng Li
Journal:  J Biol Chem       Date:  2011-11-14       Impact factor: 5.157

Review 5.  Epigenetic mechanisms in heart development and disease.

Authors:  Shannalee R Martinez; Maresha S Gay; Lubo Zhang
Journal:  Drug Discov Today       Date:  2015-01-06       Impact factor: 7.851

Review 6.  MicroRNAs: a new piece in the paediatric cardiovascular disease puzzle.

Authors:  Ahmed Omran; Dalia Elimam; Keith A Webster; Lina A Shehadeh; Fei Yin
Journal:  Cardiol Young       Date:  2013-02-26       Impact factor: 1.093

Review 7.  Cardiac small-conductance calcium-activated potassium channels in health and disease.

Authors:  Xiao-Dong Zhang; Phung N Thai; Deborah K Lieu; Nipavan Chiamvimonvat
Journal:  Pflugers Arch       Date:  2021-02-23       Impact factor: 3.657

8.  RNA expression profiling of human iPSC-derived cardiomyocytes in a cardiac hypertrophy model.

Authors:  Praful Aggarwal; Amy Turner; Andrea Matter; Steven J Kattman; Alexander Stoddard; Rachel Lorier; Bradley J Swanson; Donna K Arnett; Ulrich Broeckel
Journal:  PLoS One       Date:  2014-09-25       Impact factor: 3.240

9.  Carvedilol Alters Circulating MiR-1 and MiR-214 in Heart Failure.

Authors:  Elham Shirazi-Tehrani; Negar Firouzabadi; Gholamhossein Tamaddon; Ehsan Bahramali; Asma Vafadar
Journal:  Pharmgenomics Pers Med       Date:  2020-09-03

Review 10.  Left ventricular hypertrophy and sudden cardiac death.

Authors:  Grigorios Giamouzis; Apostolos Dimos; Andrew Xanthopoulos; John Skoularigis; Filippos Triposkiadis
Journal:  Heart Fail Rev       Date:  2021-06-28       Impact factor: 4.214

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.